ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Certain Metabolic Syndrome Component Combinations are Linked to Increased Risk of Hypogonadism in Taiwanese Men.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study examined the association between specific combinations of metabolic syndrome (MS) components and the risk of hypogonadism in Taiwanese men. Patients and Methods: We retrospectively analyzed 6,986 men who underwent health screening from 2009 to 2017. MS was defined as meeting at least three of five criteria: waist circumference (W), triglycerides (T), high-density lipoprotein cholesterol (H), fasting glucose (F), and blood pressure (B). Hypogonadism was defined as total testosterone <300 ng/dL. Differences in MS component prevalence between men with and without hypogonadism were compared. Logistic regression adjusted for age and body mass index was used to assess associations. Results: Among all participants, 6,221 (89.0%) had hypogonadism. The prevalence of MS components was significantly higher in this group (p < 0.001). The risk of hypogonadism increased with the number of MS compon ents. Notably, the combinations F-H-W, F-H-B-W, and F-T-H-B-W were associated with significantly higher odds of hypogonadism. Conclusion: Specific MS component combinations are strongly associated with increased hypogonadism risk in Taiwanese men. These findings suggest that MS composition, not just its presence, should be considered in evaluating testosterone deficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.